What is the appropriate way to write a naproxen prescription, including dosage, administration instructions, quantity, and refill limits?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Write a Naproxen Prescription

For prescription naproxen, write for 500 mg twice daily (BID) with food, dispense 60 tablets, with appropriate refills based on duration of therapy, and always include a medication guide per FDA requirements 1, 2.

Standard Prescription Format

Dosing Specifications

  • Standard dose: Naproxen 500 mg orally twice daily (BID)
  • Alternative doses available: 250 mg three times daily or 375 mg twice daily 1
  • Administration: Take with food or milk to minimize GI upset
  • Duration: Typically 7-14 days for acute conditions; longer for chronic inflammatory conditions

Quantity and Refills

  • Acute pain: Dispense 30-60 tablets (15-30 day supply at 500 mg BID)
  • Chronic conditions: Dispense 60-180 tablets with appropriate refills
  • FDA requirement: Must include instruction to "Dispense the Medication Guide provided separately to each patient" 2

Sample Prescription

Naproxen 500 mg tablets
Sig: Take 1 tablet by mouth twice daily with food
Disp: 60 tablets
Refills: 0-3 (depending on indication)
Note: Dispense Medication Guide to patient

Critical Safety Considerations Before Prescribing

High-Risk Patients Requiring Gastroprotection

Add a proton pump inhibitor (PPI) or avoid NSAIDs entirely in patients with:

  • Age >75 years (1 in 110 annual GI bleeding risk vs. 1 in 2,100 for age <45) 1
  • History of NSAID-associated GI bleeding (5% recurrence risk in 6 months even with PPI) 1
  • Concurrent anticoagulant use (5-6 times increased bleeding risk) 1
  • History of peptic ulcer disease

Cardiovascular Contraindications

Avoid naproxen in:

  • Patients with congestive heart failure
  • Recent myocardial infarction or elevated cardiovascular risk
  • Poorly controlled hypertension (NSAIDs increase BP by mean 5 mmHg) 1

Hepatic and Renal Precautions

  • Avoid in cirrhosis due to bleeding and renal complications 1
  • Dose reduction not typically required in mild hepatic/renal impairment, but start low and titrate 3

Dosing Alternatives Based on Clinical Context

For Acute Pain (sprains, postoperative, dental)

  • 500 mg BID is standard and effective 4, 5, 6
  • As-needed (PRN) dosing: 500 mg PRN has similar efficacy to scheduled BID with better safety profile and lower total drug consumption 4
  • Median time to rescue medication: 8.9 hours with naproxen vs. 2 hours with placebo 5

For Chronic Inflammatory Conditions

  • 500 mg BID or 250 mg TID are equivalent options 1
  • Once or twice daily dosing improves compliance due to naproxen's 14-hour half-life 7

Common Pitfalls to Avoid

  1. Forgetting the Medication Guide: FDA mandates dispensing the guide with each prescription 2
  2. Ignoring age-related risk: GI bleeding risk increases dramatically with age—consider PPI co-prescription for patients >65 1
  3. Combining with anticoagulants without gastroprotection: This quintuples bleeding risk 1
  4. Prescribing in heart failure patients: NSAIDs worsen fluid retention and cardiovascular outcomes 1
  5. Exceeding 2 days/week chronic use: Risk of medication overuse headache and renal complications 8

Cost Considerations

Generic naproxen 500 mg BID costs approximately $18/month, making it one of the most cost-effective NSAIDs available 1. This is substantially cheaper than branded alternatives while maintaining equivalent efficacy.

References

Guideline

nsaid prescribing precautions.

American family physician, 2009

Research

Naproxen for Post-Operative Pain.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2021

Research

What a pain in the … back: a review of current treatment options with a focus on naproxen sodium.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2024

Research

2022 Taiwan Guidelines for Acute Treatment of Migraine.

Acta neurologica Taiwanica, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.